The APTURE Transcatheter Shunt: Technology Demonstration and Rationale of the ALT FLOW II Trial 8:23 AM – 8:30 AM PDT

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Sino Medical Sciences Techologies; Orchestra Biomed Inc; Shockwave; Elixir Medical Corp; CeleCor; Foldax; JC Medical Inc.</li><li>Equity/Stock(s)/Options - Ablative Solutions, Inc</li><li>Industry-Funded Research - Edwards Lifesciences</li></ul>